Skip to content

Related research on new index diagnosis to diagnose preoperative infection during second-stage joint revision and guide the timing of surgery

Related research on new index diagnosis to diagnose preoperative infection during second-stage joint revision and guide the timing of surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500095537
Enrollment
Unknown
Registered
2025-01-08
Start date
2025-01-20
Completion date
Unknown
Last updated
2025-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic periprosthetic joint infection

Interventions

Gold Standard:2018 ICM diagnostic criteria for PJI: Two positive cultures or the presence of a sinus tract were considered as major criteria and diagnostic of PJI. The calculated weights of an elevate
Index test:The preoperative C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), interleukin-6 (IL-6), fibrinogen(Fib), neutrophil-to-lymphocyte ratio (NLR), platelet to lymphocyte ratio (P

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
21 Years to 83 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria included patients who underwent debridement for PJI, implantation of temporary antibiotic spacers, and removal of spacers and reimplantation arthroplasty.

Exclusion criteria

Exclusion criteria: Exclusion criteria included: (1) PJI patients with inflammatory joint diseases such as rheumatoid arthritis, ankylosing spondylitis, and systemic lupus erythematosus; (2) patients had venous thromboembolism (VTE), including pulmonary embolism (PE) or deep venous thrombosis (DVT), 6 weeks before reimplantation; (3) patients with other hematological or cardiovascular diseases that require antithrombotic drugs ; (4) patients who had previously undergone two-stage revision surgery; (5) patients with multiple joint infections simultaneously.

Design outcomes

Primary

MeasureTime frame
C-reactive protein;Erythrocyte sedimentation rate, ESR;Interleukin-6;Fibrinogen;Monocyte to lymphocyte ratio (MLR);Neutrophil-to-lymphocyte ratio (NLR);Platelet to lymphocyte ratio (PLR);CRP/albumin ratio (CAR);CRP to lymphocyte ratio (CLR);CRP to fibrinogen ratio (CFR) ;

Countries

China

Contacts

Public ContactZeyu Huang

West China Hospital, Sichuan University

Zey.huang@gmail.com+86 189 8060 2287

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026